Implementation of Actinic Keratosis Guideline Among General Practitioners.
NCT05976048 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-04-04
Summary
This study investigates 5-fluorouracil cream prescription trends by general practitioners for the treatment of field changes of actinic keratosis over the years 2016-2021. The aim is to analyse whether the publication of the multidisciplinary guideline on suspect skin lesions for general practitioners in 2017 has made an impact in the prescribing behaviour of general practitioners.
Conditions
- Actinic Keratoses
Sponsors & Collaborators
-
Maastricht University Medical Center
lead OTHER
Principal Investigators
-
Klara Mosterd, prof.dr. · Maastricht UMC+
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-01
- Primary Completion
- 2022-09-01
- Completion
- 2025-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses
NCT06851507 ·Status: RECRUITING ·Phase: PHASE3
-
Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses
NCT02289768 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
NCT03279328 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis
NCT01656226 ·Status: UNKNOWN ·Phase: PHASE4
-
An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses
NCT00377273 ·Status: COMPLETED ·Phase: PHASE4
-
Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
NCT05260073 ·Status: COMPLETED
-
Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis
NCT00987246 ·Status: COMPLETED ·Phase: PHASE3
-
Actinic Keratosis Study
NCT02019355 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
NCT02281682 ·Status: UNKNOWN ·Phase: PHASE4
-
Imiquimod and Actinic Keratoses: an Observational Study
NCT01151956 ·Status: COMPLETED
-
Cryosurgery and Cream Combination for Actinic Keratosis
NCT03037541 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Topical Therapy for Treatment of Scalp Actinic Keratoses
NCT03996252 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK
NCT00308867 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis
NCT05078827 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
NCT00603798 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel
NCT00427050 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
NCT02616601 ·Status: COMPLETED ·Phase: PHASE3
-
PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK
NCT03511326 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Lipikar Urea 30% Before Actinic Keratoses Treatment
NCT06274320 ·Status: RECRUITING ·Phase: NA
-
LAS41005 in Hyperkeratotic Actinic Keratosis
NCT01358851 ·Status: COMPLETED ·Phase: PHASE2
-
Gene and Protein Expression Profiles After Treatment of Actinic Keratoses
NCT05740969 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period
NCT03116698 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
NCT00605176 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
NCT00989313 ·Status: COMPLETED
-
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
NCT00375739 ·Status: COMPLETED ·Phase: PHASE2